Jellagen
PrivateLast Round
Series A
Dec 7, 2022
Total Funding Raised
$21.52M
Company Overview
Jellagen operates in Healthcare & Life Sciences and is based in Cardiff. Its latest recorded funding round was a Series A round in December 2022.
Jellagen is a biotechnology company that develops and manufactures medical-grade Collagen Type 0 from jellyfish for use in tissue engineering and regenerative medicine.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Advanced Materials, Medical Devices, Sustainable Materials
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Jellagen Comparables
Compare Jellagen with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Symatese | 74% | |
| Evergen | 73% | |
| CollPlant Biotechnologies Ltd. | 73% |
For institutional investors. Book with your work email.
Jellagen Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 7, 2022 | ||||
| Seed | Jun 25, 2020 | ||||
| Seed | May 3, 2018 | ||||
| Seed | Apr 6, 2016 | ||||
| Grant | May 1, 2015 | ||||
Grant | Oct 17, 2014 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Jellagen Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Angels Invest Wales | Seed |
| South West Angel and Investor Network | Seed |
| Cardiff Capital Region | Series A |
| Newable Private Investing | Seed |
| Innovate UK | Grant |
| Angels in MedCity | Seed |
| Development Bank of Wales | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 20, 2026
Monthly visitors grew 148% MoM, reaching 1.6K.
- Jan 6, 2026
Monthly visitors grew 374% MoM, reaching 3.1K.
For institutional investors. Book with your work email.
Jellagen Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Jellagen's valuation, stock price, and market status.
Is Jellagen a public or private company?
Jellagen is a private company.
What is the current stock price of Jellagen?
Jellagen is a private company, so its shares have no public market price. Caplight tracks Jellagen's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Jellagen worth (valuation)?
Valuation information for Jellagen is not publicly available.
Can I buy Jellagen stock?
Jellagen shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Jellagen's last funding round?
Jellagen's most recent funding round was Series A on December 7, 2022.
Who are the main investors in Jellagen?
Key investors in Jellagen include Cardiff Capital Region, Newable Private Investing, Innovate UK, Angels in MedCity, Development Bank of Wales.
Will Jellagen IPO soon?
No public IPO plans have been announced for Jellagen.
How can I track Jellagen secondary market activity?
Caplight tracks bids, offers, and trades in Jellagen's shares on secondary markets.